Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 07, 2010 14:19 ET | Source: Harbor BioSciences, Inc.

Harbor BioSciences Apoptone(R) for Prostate Cancer Shows Activity at All Doses Tested

CHICAGO, June 7, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today presented new positive data from its ongoing Phase I/IIa clinical trial with Apoptone® (HE3235) for...
June 07, 2010 08:44 ET | Source: Harbor BioSciences, Inc.

Harbor BioSciences Announces $2.06 Million Equity Financing

SAN DIEGO, June 7, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) announced today that it has entered into an agreement with certain institutional investors to raise approximately...
May 17, 2010 08:00 ET | Source: Harbor BioSciences, Inc.

Harbor BioSciences Apoptone(R) Clinical Results Poster Selected for ASCO Annual Meeting

SAN DIEGO, May 17, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today announced that new data from the Phase I/IIa clinical trial of the company's lead drug candidate...
May 10, 2010 08:00 ET | Source: Harbor BioSciences, Inc.

Triolex(R) Demonstrates Evidence of Anti-Inflammatory Activity in a Phase IIa Clinical Trial in a Subset of Type 2 Diabetes Mellitus Patients

SAN DIEGO, May 10, 2010 (GLOBE NEWSWIRE) -- Harbor Biosciences (Nasdaq:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
March 17, 2010 16:30 ET | Source: Harbor BioSciences, Inc.

Harbor BioSciences Announces Listing Transfer to The Nasdaq Capital Market

SAN DIEGO, March 17, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today announced that NASDAQ has approved its application to transfer its stock listing to The Nasdaq Capital Market...
March 08, 2010 08:00 ET | Source: Harbor BioSciences, Inc.

Harbor BioSciences Reports New Phase I/IIa Data at ASCO Symposium and Announces Plans to Advance Prostate Cancer Treatment Apoptone(R) to Phase IIb

SAN DIEGO, March 8, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences Inc. (Nasdaq:HRBR) said today it had reported encouraging data from its ongoing Phase I/IIa clinical trial with Apoptone® (HE3235)...
March 01, 2010 08:30 ET | Source: Harbor BioSciences, Inc.

Harbor BioSciences to Present Results on Lead Drug Candidate Apoptone(R)

SAN DIEGO, March 1, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today announced it will present a poster at the ASCO Genitourinary Cancers Symposium in San Francisco this week,...